Khaled Taghlabi

Dr. Khaled Taghlabi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2022 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
RWRachel Weihe
Rachel Weihe
KTKhaled Taghlabi
Khaled Taghlabi
MLMaren Lowrance
Maren Lowrance
ARAlan Reeves
Alan Reeves
SJSean R Jackson
Sean R Jackson
WAWissam El Atrouni
Wissam El Atrouni
Background: Vertebral osteomyelitis is a serious condition that requires prompt diagnosis to avoid delays in proper management. There is no well-defined gold standard for diagnosis. We describe the current diagnostic approach at our institution, with a focus on the yield of image-guided vertebral biopsy. Methods: We performed a single-centre 10-year retrospective case series, including adults with imaging suggestive of vertebral osteomyelitis/discitis, with either positive blood cultures, and/or a vertebral biopsy. We defined positive histopathology as our gold standard for test characteristic evaluation of biopsy cultures. Results: Out of 694 patients identified, 221 met our inclusion criteria, and 173/221 (78.2%) patients underwent a spinal biopsy. Of those patients with biopsies, 113 (65%) had received antibiotics within 2 weeks preceding their evaluation. Six of 43 (13.9%) bone specimens were positive by culture, while 66/152 (43.4%) of disc specimens were culture positive. Forty-seven of 84 (55.9%) histopathology (bone or disc) specimens were diagnostic for osteomyelitis/discitis. The sensitivity of bone and disk culture were 30.0% and 56.0%, respectively, with specificities of 92.8% and 75.0%, respectively. Twenty-three (13.4%) patients had repeat biopsies, including 10 bone specimens and 14 disc specimens, and 11 (47.8%) specimens had histopathology performed which diagnosed an additional 3/23 patients (13% additional diagnostic yield). Conclusions: Culture of percutaneous biopsy of disc resulted in the highest diagnostic yield. Histopathology added to the diagnostic yield in culture-negative specimens. Histopathologic evaluation of bone had better yield than bone culture. A repeat biopsy can add to the diagnostic yield.

12 May 2024 in World Neurosurgery
Verified
Journal Article
Closed access
KTKhaled Taghlabi
Khaled Taghlabi
AQAhmad A. Quaddoura
Ahmad A. Quaddoura
ANArsalan Nisar
Arsalan Nisar
PGParas Gupta
Paras Gupta
LBLokeshwar S. Bhenderu
Lokeshwar S. Bhenderu
AFAmir H. Faraji
Amir H. Faraji

12 July 2022 in North American Spine Society Journal (NASSJ)
Verified
Journal Article
Open access
KTKhaled Taghlabi
Khaled Taghlabi
BCBrandon B. Carlson
Brandon B. Carlson
JBJoshua Bunch
Joshua Bunch
RJR. Sean Jackson
R. Sean Jackson
RWRobert Winfield
Robert Winfield
DBDouglas C. Burton
Douglas C. Burton
Prophylactic anticoagulation is commonly used following operative treatment of spinal fractures to prevent Venous Thromboembolism (VTE) but carries a risk of bleeding complications. The purpose of the study was to compare VTE and bleeding complications for MID (≤72h) versus LATE (>72h) chemoprophylaxis timing after spinal fracture operative intervention. This is a retrospective review of patients treated for spinal fractures that received anticoagulation chemoprophylaxis between May 2015 and June 2019. Chemoprophylaxis initiation timing (MID vs. LATE) was the primary grouping variable. Patients with traumatic brain injury or evidence of intracranial or intraspinal bleed were excluded. Demographics, injury mechanisms, operative procedures, timing of administration of VTE prophylaxis, Injury Severity Score (ISS) and Spine Abbreviated Injury Scale (AIS), and complications including VTE and bleeding complications were collected. Predictors of VTE were identified using a binary logistic regression. Eighty-eight patients (65M, 23F) met inclusion criteria. The median age was 55 years, and median Injury Severity Score (ISS) was 14. MID had 68 patients and LATE had 20. Nine patients developed VTE (6 LATE, 3 MID, p<0.01). Three patients developed bleeding complications, and all occurred in the LATE group (p=0.01). ISS (p<0.01) and GCS (p<0.01) also correlated with an increased VTE rate. Chemoprophylactic anticoagulation at 72 hours in surgically treated spinal fracture patients demonstrates a lower VTE rate without increasing complications. VTE prophylaxis can be initiated at 72 hours following spine fixation to decrease postinjury morbidity and mortality in this high-risk patient population.

1 February 2024 in Journal of Neural Engineering
Verified
Journal Article
Open access
KTKhaled Taghlabi
Khaled Taghlabi
JCJesus Gabriel Cruz-Garza
Jesus Gabriel Cruz-Garza
THTaimur Hassan
Taimur Hassan
OPOjas Potnis
Ojas Potnis
LBLokeshwar Bhenderu
Lokeshwar Bhenderu
AFAmir H Faraji
Amir H Faraji
Peripheral nerve interfaces (PNIs) are electrical systems designed to integrate with peripheral nerves in patients, such as following central nervous system (CNS) injuries to augment or replace CNS control and restore function. We review the literature for clinical trials and studies containing clinical outcome measures to explore the utility of human applications of PNIs. We discuss the various types of electrodes currently used for PNI systems and their functionalities and limitations. We discuss important design characteristics of PNI systems, including biocompatibility, resolution and specificity, efficacy, and longevity, to highlight their importance in the current and future development of PNIs. The clinical outcomes of PNI systems are also discussed. Finally, we review relevant PNI clinical trials that were conducted, up to the present date, to restore the sensory and motor function of upper or lower limbs in amputees, spinal cord injury patients, or intact individuals and describe their significant findings. This review highlights the current progress in the field of PNIs and serves as a foundation for future development and application of PNI systems.

17 July 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
JCJesus Gabriel Cruz-Garza
Jesus Gabriel Cruz-Garza
LBLokeshwar Bhenderu
Lokeshwar Bhenderu
KTKhaled Taghlabi
Khaled Taghlabi
KFKendall P. Frazee
Kendall P. Frazee
JGJaime R. Guerrero
Jaime R. Guerrero
AFAmir H. Faraji
Amir H. Faraji
Electrokinetic convection-enhanced delivery (ECED) utilizes an external electric field to drive the delivery of molecules and bioactive substances to local regions of the brain through electroosmosis and electrophoresis, without the need for an applied pressure. We characterize the implementation of ECED to direct a neutrally charged fluorophore (3 kDa) from a doped biocompatible acrylic acid/acrylamide hydrogel placed on the cortical surface. We compare fluorophore infusion profiles using ECED (time = 30 min, current = 50 µA) and diffusion-only control trials, for ex vivo (N = 18) and in vivo (N = 12) experiments. The linear intensity profile of infusion to the brain is significantly higher in ECED compared to control trials, both for in vivo and ex vivo. The linear distance of infusion, area of infusion, and the displacement of peak fluorescence intensity along the direction of infusion in ECED trials compared to control trials are significantly larger for in vivo trials, but not for ex vivo trials. These results demonstrate the effectiveness of ECED to direct a solute from a surface hydrogel towards inside the brain parenchyma based predominantly on the electroosmotic vector.

25 April 2025 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
RTRaiyan Talukder
Raiyan Talukder
KTKhaled Taghlabi
Khaled Taghlabi
RKRayan Khan
Rayan Khan
MMMichael Melhem
Michael Melhem
RMRobert Bruce McManus
Robert Bruce McManus
AFAmir H. Faraji
Amir H. Faraji